ArticleJournal of translational medicine2025

Glutamine metabolism reprogramming promotes bladder cancer progression via PYCR1: a multi-omics and functional validation study.

Xinjia Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.